Eckert & Ziegler AG O.N. (EUZG)

Currency in EUR
15.290
0.000(0.00%)
Delayed Data·
EUZG is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
15.03015.500
52 wk Range
13.30023.083
Key Statistics
Bid/Ask
15.20 / 15.28
Prev. Close
15.29
Open
15.28
Day's Range
15.03-15.5
52 wk Range
13.3-23.083
Volume
-
Average Volume (3m)
114.69K
1-Year Change
-29.0487%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
EUZG Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
22.100
Upside
+44.54%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth

Eckert & Ziegler AG O.N. News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 22.100
(+44.54% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Berenberg
Buy23.00+50.43%24.00MaintainMay 22, 2026
Kepler Cheuvreux
Buy20.30+32.77%21.70MaintainMar 27, 2026

Earnings

Latest Release
May 12, 2026
EPS / Forecast
0.17 / --
Revenue / Forecast
72.9M / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.79%
Dividend Yield
1.44%
Industry Median 2.16%
Annualized payout
0.22
Paid annually
5-Years Growth
+7.96%
Growth Streak

EUZG Income Statement

Compare EUZG to Peers and Sector

Metrics to compare
EUZG
Peers
Sector
Relationship
P/E Ratio
0.0x19.3x−0.4x
PEG Ratio
0.000.540.00
Price/Book
0.0x3.0x2.6x
Price / LTM Sales
0.0x1.4x3.0x
Upside (Analyst Target)
0.0%27.6%51.9%
Fair Value Upside
Unlock4.9%9.4%Unlock

Eckert & Ziegler SE manufactures and sells isotope technology components in Europe, North America, Asia, and internationally. It operates through two segments, Medical and Isotope Products. The company provides small implants for the treatment of prostate cancer seeds based on iodine-125; and eye applicators based on ruthenium-106 and iodine-125 for the treatment of choroidal melanomas; brain seed, HDR and brachytherapy; therapeutic and radiotherapy accessories, X-Ray therapy, GA-68 generators, radiochromatography, hot cells; and radiopharmaceuticals, laboratory equipment, radiosynthesis equipment, quality-control equipment, consumables, therapeutic products and plant engineering, and other services. It offers standard and radiation sources for medical and industrial sectors; medical imaging and spect diagnostics, industrial analytical and instrument, high activity CS-137 and CO-60, and oil well logging sources; blood irradiators and environmental disposal source services; and bulk isotopes as well as calibration-related sources for radioisotopes. In addition, the company offers Tc-99m generators and supplies, trade in raw isotopes and other products, and services. It serves medical, scientific, and industrial applications. The company was formerly known as Eckert & Ziegler Strahlen- und Medizintechnik AG and changed its name to Eckert & Ziegler SE in March 2024. Eckert & Ziegler SE was founded in 1992 and is headquartered in Berlin, Germany.

Employees
1100
Market
Germany

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
12.12M19.36%185.27M
Other Institutional Investors
21.59M34.50%330.13M
Public Companies & Retail Investors
28.87M46.13%441.39M
Total
62.58M100.00%956.79M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Eckert Wagniskapital und Frühphasenfinanzierung GmbH31.63%19,790,040302,590
Morgan Stanley3.03%1,894,50328,967

People Also Watch

55.650
NEKG
-4.79%
38.320
JENGn
+1.22%
73.400
AOFG
-0.27%
23.500
JUNG_p
0.00%
134.50
VU
-2.68%

FAQ

What Is the Eckert&Ziegler AG (EUZG) Stock Price Today?

The Eckert&Ziegler AG stock price today is 15.290 EUR.

What Stock Exchange Does Eckert&Ziegler AG Trade On?

Eckert&Ziegler AG is listed and trades on the Frankfurt Stock Exchange.

What Is the Stock Symbol for Eckert&Ziegler AG?

The stock symbol for Eckert&Ziegler AG is "EUZG."

Does Eckert&Ziegler AG Pay Dividends? What’s The Current Dividend Yield?

The Eckert&Ziegler AG dividend yield is 1.43%.

What Is the Eckert&Ziegler AG Market Cap?

As of today, Eckert&Ziegler AG market cap is 956.800M EUR.

What Is Eckert&Ziegler AG's Earnings Per Share (TTM)?

The Eckert&Ziegler AG EPS (TTM) is 0.790.

When Is the Next Eckert&Ziegler AG Earnings Date?

Eckert&Ziegler AG will release its next earnings report on Aug 13, 2026.

From a Technical Analysis Perspective, Is EUZG a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Eckert&Ziegler AG Stock Split?

Eckert&Ziegler AG has split 4 times.

How Many Employees Does Eckert&Ziegler AG Have?

Eckert&Ziegler AG has 1100 employees.

What is the current trading status of Eckert&Ziegler AG (EUZG)?

As of Jul 09, 2026, Eckert&Ziegler AG (EUZG) is trading at a price of 15.290 EUR, with a previous close of 15.290 EUR. The stock has fluctuated within a day range of 15.030 EUR to 15.500 EUR, while its 52-week range spans from 13.300 EUR to 23.083 EUR.

What Is Eckert&Ziegler AG (EUZG) Price Target According to Analysts?

The average 12-month price target for Eckert&Ziegler AG is 22.100 EUR, with a high estimate of 23 EUR and a low estimate of 20.3 EUR. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +44.54% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.